Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals C. Torti, L. Bono, F. Gargiulo, M.C. Uccelli, E. Quiros-Roldan, A. Patroni, G. Paraninfo, V. Tirelli, N. Manca, M.A. De Francesco, F. Perandin, G. Carosi Clinical Microbiology and Infection Volume 10, Issue 9, Pages 826-830 (September 2004) DOI: 10.1111/j.1469-0691.2004.00938.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 1 Prevalence of mutations (both canonical and atypical) at positions indicated by the International AIDS Society (IAS) in HIV strains from the study patients. N(t)RTI, nucleoside (nucleotide) reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor. Clinical Microbiology and Infection 2004 10, 826-830DOI: (10.1111/j.1469-0691.2004.00938.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions